Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People

被引：53

作者：

Sanchez-Rodriguez, D. ^{[1
,2
,3
,4
,5
]}

Marco, E. ^{[2
,3
,6
,7
]}

Davalos-Yerovi, V. ^{[2
,4
,6
]}

Lopez-Escobar, J. ^{[2
,4
,6
]}

Messaggi-Sartor, M. ^{[2
,3
,6
,8
]}

Barrera, C. ^{[2
,6
]}

Ronquillo-Moreno, N. ^{[1
]}

Vazquez-Ibar, O. ^{[1
,4
]}

Calle, A. ^{[1
,3
,9
]}

Inzitari, M. ^{[3
,9
]}

Piotrowicz, K. ^{[10
]}

Duran, X. ^{[11
]}

Escalada, F. ^{[2
,3
,6
]}

Muniesa, J. M. ^{[2
,3
,6
]}

Duarte, E. ^{[2
,3
,6
]}

机构：

[1] Hosp Del Mar, Geriatr Dept, Ctr Forum, Parc Salut Mar, C Llull 410, Barcelona 08019, Spain

[2] Inst Hosp del Mar Invest Med IMIM, Hosp Del Mar Med Res Inst, Rehabil Res Grp, Barcelona, Spain

[3] Univ Autonoma Barcelona, Barcelona, Spain

[4] Univ Pompeu Fabra, Barcelona, Spain

[5] Univ Liege, Ctr Collaborateur OMS Etud Sante & Vieillissement, Res Unit Publ Hlth Epidemiol & Hlth Econ, Dept Publ Hlth Epidemiol & Hlth Econ,CHU Sart Til, Liege, Belgium

[6] Parc Salut Mar, Phys Med & Rehabil Dept, Barcelona, Spain

[7] Univ Int Catalunya, Barcelona, Spain

[8] Univ Oberta Catalunya, Barcelona, Spain

[9] Parc Sanitari Pere Virgili, Dept Hlth Care, Barcelona, Spain

[10] Jagiellonian Univ, Dept Internal Med & Gerontol, Fac Med, Krakow, Poland

[11] Inst Hosp del Mar Invest Med IMIM, Hosp Del Mar Med Res Inst, Methodol & Biostat Support Unit, Barcelona, Spain

来源：

JOURNAL OF NUTRITION HEALTH & AGING | 2019年 / 23卷 / 06期

关键词：

SARC-F; spanish; validation; sarcopenia; screening; muscle mass; FRAILTY; ICD-10;

D O I：

10.1007/s12603-019-1204-z

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

ObjectivesThe revised European consensus on sarcopenia definition and diagnosis (EWGSOP2) includes the SARC-F questionnaire, the most valid and consistent sarcopenia screening tool, as the mandatory first step. Our aim was the translation, cross-cultural adaptation, and validation of the SARC-F questionnaire as a culturally-responsive Spanish-language version for the European population.Study designCross-sectional descriptive study, applying the two-step WHO methodology for translation and cross-cultural adaptation of health questionnaires, and harmonization with the Mexican-Spanish version. European Union Geriatric Medicine Society recommendations for SARC-F validation in European languages were considered.ParticipantsOutpatient clinics of a university hospital. Inclusion criteria: stable, ambulatory (including aids), community-dwelling population 65 years old.Main outcome measuresThe self-reported 5-item SARC-F questionnaire was administered; scores 4 indicated sarcopenia. Sensitivity, specificity, accuracy-likelihood ratios, predictive values, and kappa statistics were calculated and consecutively compared with European Working Group on Sarcopenia in Older People (EWGSOP) and EWGSOP2 criteria.ResultsThis Spanish version, administered in an average 70s, has adequate internal consistency (Cronbach alpha=0.779). For the validation study, 90 (43.3%) of 208 potentially eligible subjects (81.4 5.9 years old, 75.6% women) were included. SARC-F identified 51 (56.7%) subjects with sarcopenia and 39 (43.3%) without the disease. Prevalence was 17.8% per EWGSOP and 25.6% per EWGSOP2 (58% accuracy and fair agreement: sensitivity, 783%; specificity, 50.8%).ConclusionsSARC-F is a feasible tool, suitable for bedside assessment in community-dwelling older patients. Wide diffusion of this culturally-responsible SARC-F Spanish version is expected as EWGSOP2 is adopted and sarcopenia assessment is broadly implemented in Spain.

引用

页码：518 / 524

页数：7

共 30 条

[21] SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes [J].